MarketAnalysisMarketAnalysis
NYSE:LLY

Eli Lilly and Company - NYSE:LLY - Comprehensive analysis

Free evaluation through quantitative algorithms Eli Lilly and Company - NYSE:LLY

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

32

Market

98

Sector

84

Gross Profit Growth Over Prior Year

35.4

Market

97

Sector

85

EBITDA Growth Over Prior Year

57

Market

96

Sector

91

EBITA Growth Over Prior Year

60

Market

95

Sector

88

EBIT Growth Over Prior Year

63

Market

94

Sector

87

Earnings from Cont. Ops. Growth Over Prior Year

103

Market

95

Sector

88

Net Income Growth Over Prior Year

103

Market

95

Sector

86

Normalized Net Income Growth Over Prior Year

62

Market

92

Sector

81

Diluted EPS before Extra Growth Over Prior Year

102

Market

95

Sector

87

A/R Growth Over Prior Year

21.1

Market

89

Sector

81

Inventory Growth Over Prior Year

31.5

Market

98

Sector

92

PPE Net Growth Over Prior Year

32.4

Market

96

Sector

88

Total Assets Growth Over Prior Year

23

Market

95

Sector

78

Tangible Book Value Growth Over Prior Year

0

Market

0

Sector

0

Common Equity Growth Over Prior Year

31.8

Market

92

Sector

81

Cash from Ops. Growth Over Prior Year

108

Market

98

Sector

91

CAPEX Growth Over Prior Year

46.7

Market

94

Sector

84

Dividend per Share Growth Over Prior Year

15.04

Market

90

Sector

100

Levered Free Cash Flow Growth Over Prior Year

158

Market

95

Sector

89

Unlevered Free Cash Flow Growth Over Prior Year

118

Market

93

Sector

86

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

82

Market

94

Sector

83

SG&A Margin %

18.05

Market

61

Sector

32

EBITDA Margin %

42.8

Market

82

Sector

98

EBITA Margin %

40.1

Market

92

Sector

98

EBIT Margin %

38.9

Market

93

Sector

99

Earnings from Cont. Ops Margin %

23.5

Market

82

Sector

96

Net Income Margin %

23.5

Market

82

Sector

96

Net Income Avail. for Common Margin %

23.5

Market

83

Sector

96

Normalized Net Income Margin %

23.4

Market

94

Sector

98

Levered Free Cash Flow Margin %

2.48

Market

27

Sector

64

Unlevered Free Cash Flow Margin %

3.57

Market

26

Sector

64

Return on Assets %

15.33

Market

94

Sector

99

Return on Capital %

25.6

Market

95

Sector

99

Return on Equity %

85

Market

95

Sector

100

Return on Common Equity %

85

Market

95

Sector

100

Total Asset Turnover

0.63

Market

62

Sector

73

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 18
Momentum: 38
Growth: 95
Profitability: 79

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

15.67

Market

98

Sector

84

TEV/LTM EBITDA

36.2

Market

96

Sector

92

P/LTM Normalized EPS

73

Market

92

Sector

88

P/BV

54

Market

99

Sector

99

TEV/LTM Unlevered FCF

0

Market

0

Sector

0

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

-7.27

Market

36

Sector

65

3M Price Performance

-5.25

Market

53

Sector

76

6M Price Performance

-16.89

Market

29

Sector

62

9M Price Performance

-20.19

Market

22

Sector

65

1Y Price Performance

-0.35

Market

47

Sector

78

Start analyzing Eli Lilly and Company - NYSE:LLY with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports